Golden State Equity Partners’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $1.28M | Buy |
54,289
+4,289
| +9% | +$101K | 0.31% | 79 |
|
|
2023
Q3 | $746K | Hold |
50,000
| – | – | 0.21% | 121 |
|
|
2023
Q2 | $548K | Hold |
50,000
| – | – | 0.15% | 164 |
|
|
2023
Q1 | $436K | Buy |
+50,000
| New | +$436K | 0.24% | 105 |
|
|
2022
Q1 | $157K | Buy |
50,600
+100
| +0.2% | +$310 | 0.08% | 183 |
|
|
2021
Q4 | $171K | Buy |
50,500
+17,650
| +54% | +$59.8K | 0.09% | 164 |
|
|
2021
Q3 | $120K | Buy |
+32,850
| New | +$120K | 0.05% | 224 |
|